GlassScriptPhysician profile
Yifei Sun
NPI 1477840833
$4,318.08
in general payments reported to CMS, 2019-2025
36 companies · $915 in 2025
The $915 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $779 · 2020: $61.18 · 2021: $178 · 2022: $321 · 2023: $817 · 2024: $1,248 · 2025: $915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,947 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,947.47 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $664.26 | 2019-2024 | C3 Delivery System, Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Aaa Endoprosthesis |
| Merck Sharp & Dohme LLC | $354.51 | 2023-2025 | Verquvo |
| Boston Scientific Corporation | $326.51 | 2019-2024 | Watchman Access System, Eluvia |
| Silk Road Medical, INC. | $259.54 | 2019-2021 | |
| Penumbra, INC. | $241.09 | 2023-2025 | Ruby Coil, Indigo System, Penumbra System |
| Novo Nordisk INC | $228.10 | 2024-2025 | Wegovy, Ozempic |
| Pfizer INC. | $202.12 | 2023-2025 | |
| Amgen INC. | $202.09 | 2019-2025 | Repatha, Repatha |
| Smith+Nephew, INC. | $184.54 | 2024-2025 | Grafix Pl, Collagenase Santyl, Stravix Pl |
| Janssen Pharmaceuticals, INC | $178.67 | 2019-2024 | Xarelto |
| Kerecis Limited | $150.58 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Bolton Medical INC | $149.37 | 2025 | Treo Abdominal Stent-Graft System |
| Osiris Therapeutics INC. | $122.75 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.99 | 2022-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $110.05 | 2021-2023 | Eliquis |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $74.02 | 2019-2025 | Farxiga |
| Integra Lifesciences Corporation | $71.90 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Inari Medical, INC. | $69.51 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Endologix LLC | $68.29 | 2022 | |
| Medtronic Vascular, INC. | $61.50 | 2019 | |
| Davol INC. | $49.66 | 2024 | Covera |
| Bard Peripheral Vascular, INC. | $48.91 | 2021-2024 | Covera |
| Kiniksa Pharmaceuticals International, Plc | $45.58 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $44.98 | 2024 | |
| Aroa Biosurgery Incorporated | $39.51 | 2025 | |
| Organogenesis INC. | $38.48 | 2023-2025 | Puraply, Puraply Wound Matrix |
| Becton, Dickinson and Company | $32.77 | 2024 | Lutonix Drug Coated Balloon |
| Novartis Pharmaceuticals Corporation | $31.60 | 2023 | |
| Urgo Medical North America, LLC | $25.88 | 2024 | Urgoclean Ag |
| Tactile Systems Technology INC | $23.55 | 2019 | |
| Philips North America LLC | $18.08 | 2023 | |
| Heartflow, INC. | $17.21 | 2024 | |
| Solventum Corporation | $15.71 | 2024 | Activ.A.C. |
| Polynovo North America LLC | $15.27 | 2025 | Novosorb Btm |
| Scpharmaceuticals INC. | $15.11 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.39 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yifei Sun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.